{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:15:06Z","timestamp":1791267306582,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1212\/wnl.53.9.2151","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:42:43Z","timestamp":1336916563000},"page":"2151-2151","source":"Crossref","is-referenced-by-count":85,"title":["The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine"],"prefix":"10.1212","volume":"53","author":[{"given":"Roy","family":"Freeman","sequence":"first","affiliation":[{"name":"From the Department of Neurology (Dr. Freeman)Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA; and the Department of Medicine (Drs. Landsberg and Young), Northwestern University Medical School, Northwestern University, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Landsberg","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (Dr. Freeman)Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA; and the Department of Medicine (Drs. Landsberg and Young), Northwestern University Medical School, Northwestern University, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Young","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (Dr. Freeman)Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA; and the Department of Medicine (Drs. Landsberg and Young), Northwestern University Medical School, Northwestern University, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1960.03840110025004"},{"key":"e_1_3_2_3_2","unstructured":"Bannister R Mathias CJ. Clinical features and investigations of the primary autonomic failure syndromes. In: Bannister R Mathias CJ eds. Autonomic Failure. Oxford:Oxford University Press 1992:531\u2013547."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","unstructured":"Position paper: orthostatic hypotension multiple system atrophy (the Shy Drager syndrome) and pure autonomic failure. J Auton Nerv Syst 1996;58:123\u2013124.","DOI":"10.1016\/0165-1838(96)90001-6"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(25)90007-5"},{"key":"e_1_3_2_6_2","unstructured":"Low PA McLeod JG. The autonomic neuropathies. In: Low PA ed. Boston:Little Brown and Company 1993:395\u2013421."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197702102960601"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410260410"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6.1370"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6.1414"},{"key":"e_1_3_2_11_2","first-page":"1","volume":"121","year":"1953","unstructured":"Whitney RJ. The measurement of volume changes in human limbs. J Physiol (Lond) 1953;121:1\u201327.","journal-title":"J Physiol (Lond)"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112763"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199108000-00002"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004691-199301000-00007"},{"key":"e_1_3_2_15_2","unstructured":"Fealey RD Robertson D. Management of orthostatic hypotension. In: Low PA editor. Clinical autonomic disorders. Boston:Little Brown and Company 1993:731\u2013743."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540370036033"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3565(25)30169-2","volume":"193","year":"1975","unstructured":"Bartholini J, Constantinidis J, Puig M, Tissot R, Pletscher A. The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine. J Pharmacol Exp Ther 1975;193:523\u2013532.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00605999"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00504861"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(78)90161-2"},{"key":"e_1_3_2_21_2","first-page":"1170","volume":"2","year":"1987","unstructured":"Biaggioni I, Robertson D. Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency. Lancet 1987;2:1170\u20131172.","journal-title":"Lancet"},{"key":"e_1_3_2_22_2","first-page":"1172","volume":"2","year":"1987","unstructured":"Man in\u2019t Veld AJ, Boomsma F, van den Meiracker AH, Schalekamp MA. Effect of unnatural noradrenaline precursor on sympathetic control and orthostatic hypotension in dopamine-beta-hydroxylase deficiency. Lancet 1987;2:1172\u20131175.","journal-title":"Lancet"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.7.1091"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02260889"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410290602"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(95)00155-U"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430205"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.2042-7158.1978.tb13289.x","volume":"30","year":"1978","unstructured":"Araki H, Cheng JT, Ohmura I, Tanaka C. Positive chronotropic effect of threo-3,4-dihydroxyphenylserine as a precursor of noradrenaline in rat isolated atria. J Pharm Pharmacol 1978;30:456\u2013458.","journal-title":"J Pharm Pharmacol"},{"key":"e_1_3_2_29_2","first-page":"175P.","volume":"40","year":"1986","unstructured":"Nakahara H, Matsui K, Hara Y. Evaluation of hemodynamic change induced by catecholamines and their precursors in open-chest rats. Jpn J Pharmacol 1986;40 (Supp):175P.","journal-title":"Jpn J Pharmacol"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.6.951"},{"key":"e_1_3_2_31_2","unstructured":"Freeman R. Treatment of orthostatic hypotension\u2014Midodrine and other pressor drugs. In: Robertson D Low PA Polinsky RJ eds. Primer on the autonomic nervous system. New York:Academic Press 1996:326\u2013332."}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/full\/10.1212\/WNL.53.9.2151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T22:49:20Z","timestamp":1743115760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.53.9.2151"}},"subtitle":["A randomized, placebo-controlled, crossover trial"],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["10.1212\/WNL.53.9.2151"],"URL":"https:\/\/doi.org\/10.1212\/wnl.53.9.2151","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}